HOME >> MEDICINE >> NEWS
Molecular test proves to be effective in measuring remission and relapse after cancer treatment

An international consortium of researchers from Seattle, London and Australia have reported the first use of a sensitive molecular test to measure the precise extent of remission or the likelihood of relapse in cancer patients being treated on Gleevec or a combination therapy consisting of interferon and cytarabine. The test is hundreds of thousands of times more sensitive than any other test making it a way to detect relapse earlier than ever before. Currently used to monitor the disease status of patients with chronic myelogenous leukemia after treatment with a bone-marrow or stem-cell transplant, the molecular test enables physicians to respond quickly if there are signs of relapse with treatment decisions that has ultimately saved lives.

In a study published in the Oct. 9 issue of the New England Journal of Medicine, Drs. Tim Hughes at the Institute of Medical and Veterinary Science in Adelaide, Australia, Jerry Radich at Fred Hutchinson and Jaspal Kaeda at Hammersmith in London used molecular analysis to detect residual cancer cells in leukemia patients enrolled in a clinical trial to compare two drug regimens. The researchers found their method which is based on a technique called polymerase chain reaction, or PCR, to be far more stringent at picking up traces of cancer that could lead to relapse than the standard test known as cytogenetic analysis, in which chromosomes are examined under a microscope.

The study was part of a large international clinical trial to compare the response of patients with chronic myeloid leukemia to Gleevec, a recently approved drug manufactured by Novartis, with a combination therapy consisting of interferon and cytarabine.

According to Radich, the study, which is the first to use the technique to assess the extent of response to drug therapy, opens the door to a new conceptual approach for the design of future clinical trials.

"Our results tell us that PCR can be used to stratify patients accor
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
8-Oct-2003


Page: 1 2 3 4 5

Related medicine news :

1. Molecular test predicts risk of breast cancer recurrence and who will benefit from chemotherapy
2. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
3. Molecular tailoring of chemotherapy with novel imaging techniques
4. Molecular clock genes influence metabolism of sugar and dietary fats
5. Data announced at ISHLT: Molecular testing proves effective in monitoring heart transplant rejection
6. Molecular analyses of leukemia patients suggest strategies for better treatments
7. Molecular tag pinpoints which breast cancer tumors are most likely to spread
8. Molecular mechanism underlaying anthrax infection described by UCSD School Of Medicine researchers
9. Molecularly targeted drug slows tumor growth in patients
10. Molecular self-assembly techniques used to coat biomedical substrates
11. Molecular nanogenerator developed that can target cancer cells and destroy them

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... CITY, Mich. (PRWEB) , ... May 21, 2020 , ... ... a hands-free door opener that allows users to open swing-style doors without using ... doors and allows people to pull the door open using their forearm, wrist or ...
(Date:5/21/2020)... ... , ... A Safe Haven Foundation (ASHF) has been selected as one of ... Resilience Fund. The fund was created in March to help nonprofits with their immediate ... to vulnerable populations in hard-hit communities. , “We are humbled and honored to ...
(Date:5/21/2020)... ... May 21, 2020 , ... The Rise of Mental Health and ... lot of complications and adjustments, needless to say, more complications. With rising deaths, more ... great depression it can be hard to escape and find peace. Adding to these ...
(Date:5/17/2020)... ... May 18, 2020 , ... ... therapy program at its Tijuana regenerative clinic. There are two program options for ... safe cell counts. , While it is unclear exactly what causes Autism Spectrum ...
(Date:5/16/2020)... ... 16, 2020 , ... Dr. Tomasz Biernacki states that “If bunion ... from developing. This can keep the foot from being unable to fit into good ... the people who develop flat feet and bunion formation can have further ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... ... Foundation today announced a unique set of retail offers and recognized a ... to frontline healthcare. While millions of PPE units have arrived to hospitals through ...
(Date:5/16/2020)... ... May 17, 2020 , ... ... with a physician, can provide primary care, injury and illness prevention, wellness ... rehabilitation of injuries and medical conditions. Secondary schools and colleges/universities employ a ...
(Date:5/16/2020)... ... 2020 , ... Oakworks Medical, a leading manufacturer of Ultrasound, C-arm, and Exam ... face down for extended periods and possibly prevent them from needing a ventilator. ... Pain Management professionals. We used our expertise to design a proning cushion that comfortably ...
Breaking Medicine Technology:
Cached News: